PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Sep-2023 Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin® Ligand Discovery Using Cutting-Edge AI and Molecular Modeling Techniques B3C newswire
06-Sep-2023 Evolva receives approval for Veri-teTM Resveratrol in Thailand Evolva Holding SA
05-Sep-2023 Biomunex is nominated for the Prix Galien USA in the "Best Startup" category, further recognizing the innovative nature of its bi- and multi-specific antibody technologies in immunotherapy of cancer Biomunex
05-Sep-2023 Epigenomics AG: Pareto and Warburg publish analyst research reports Epigenomics AG
05-Sep-2023 Zenas BioPharma Announces Strategic License and Collaboration Agreement with Bristol Myers Squibb to Develop and Commercialize Novel Bi-Functional Antibody Obexelimab in Japan, South Korea, Taiwan, Singapore, Hong Kong and Australia Zenas BioPharma
05-Sep-2023 New Sales Contract with UK Pharmaceutical Company Celadon Pharmaceuticals Plc
05-Sep-2023 Pharmadoctor supports hundreds of community pharmacies to offer their patients Wegovy for the first time in the UK Pharmadoctor
05-Sep-2023 Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market Mainz BioMed N.V.
05-Sep-2023 Biotest AG: Biotest treats first shingles patient with Varitect® CP in VARIZOSTA study Biotest AG
05-Sep-2023 iOmx Therapeutics appoints Dr. Nils Peter Debus as Chief Business Officer iOmx Therapeutics AG
05-Sep-2023 DEFENCE’S INNOVATIVE THERAPEUTICS FEATURED ON VIEWPOINT WITH DENNIS QUAID Defence Therapeutics Inc.
04-Sep-2023 Biophytis to Participate at the H.C. Wainwright 25th Global Investment Conference in New York Biophytis
04-Sep-2023 AbbVie’s AQUIPTA® (atogepant) receives MHRA marketing authorisation for the prevention of migraines in adults AbbVie
04-Sep-2023 Biotest AG: Biotest Supervisory Board extends Management Board contract of Dr Jörg Schüttrumpf by 5 years Biotest AG
04-Sep-2023 Cosmo and Adalvo sign License and Supply Agreement for Rifamycin SV MMX® 200mg in Europe, APAC, MENA and LATAM regions Cosmo Pharmaceuticals N.V.
04-Sep-2023 Termination of Agreement for Rifamycin SV MMX® with Dr. Falk Pharma Cosmo Pharmaceuticals N.V.
01-Sep-2023 IMed Consultancy releases guide to Market Entry looking at the EU, the UK and the USA IMed Consultancy
01-Sep-2023 Telecan°: Germany’s largest medical cannabis company launches online platform for cannabis on prescription  Cantourage Group SE
01-Sep-2023 M1 Kliniken AG: Market leader for beauty medicine in Germany opens up in the 9th foreign market and prepares market entry in the USA M1 Kliniken AG
01-Sep-2023 Relief Therapeutics to Participate in the H.C. Wainwright 25th Annual Global Investment Conference Relief Therapeutics Holding SA